|
1
|
Ahmad R, Alam M, Hasegawa M, Uchida Y,
Al-Obaid O, Kharbanda S and Kufe D: Targeting MUC1-C inhibits the
AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal
cancer. Mol Cancer. 16:332017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang C, Yue Y, Shao B, Qiu Z, Mu J, Tang
J, Han X, Xiang T and Ren G: Dickkopf-related protein 2 is
epigenetically inactivated and suppresses colorectal cancer growth
and tumor metastasis by antagonizing Wnt/β-catenin signaling. Cell
Physiol Biochem. 41:1709–1724. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in china,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peeters M, Price T and Van Laethem JL:
Anti-epidermal growth factor receptor monotherapy in the treatment
of metastatic colorectal cancer: Where are we today? Oncologist.
14:29–39. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li J, Zhang N, Zhang R, Sun L, Yu W, Guo
W, Gao Y, Li M, Liu W, Liang P, et al: CDC5L promotes htert
expression and colorectal tumor growth. Cell Physiol Biochem.
41:2475–2488. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kelly C and Cassidy J: Chemotherapy in
metastatic colorectal cancer. Surg Oncol. 16:65–70. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qi J, Yu Y, Akilli Ozturk O, Holland JD,
Besser D, Fritzmann J, Wulf-Goldenberg A, Eckert K, Fichtner I and
Birchmeier W: New Wnt/β-catenin target genes promote experimental
metastasis and migration of colorectal cancer cells through
different signals. Gut. 65:1690–1701. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hagan S, Orr MC and Doyle B: Targeted
therapies in colorectal cancer-an integrative view by PPPM. EPMA J.
4:32013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ou B, Zhao J, Guan S, Feng H, Wangpu X,
Zhu C, Zong Y, Ma J, Sun J, Shen X, et al: CCR4 promotes metastasis
via ERK/NF-κB/MMP13 pathway and acts downstream of TNF-α in
colorectal cancer. Oncotarget. 7:47637–47649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alberts SR, Horvath WL, Sternfeld WC,
Goldberg RM, Mahoney MR, Dakhil SR, Levitt R, Rowland K, Nair S,
Sargent DJ, et al: Oxaliplatin, fluorouracil, and leucovorin for
patients with unresectable liver-only metastases from colorectal
cancer: A north central cancer treatment group phase ii study. J
Clin Oncol. 23:9243–9249. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jove R: Preface: STAT signaling. Oncogene.
19:2466–2467. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Uchiyama T, Takahashi H, Endo H, Sugiyama
M, Sakai E, Hosono K, Nagashima Y, Inayama Y, Wada K, Hippo Y, et
al: Role of the long form leptin receptor and of the STAT3
signaling pathway in colorectal cancer progression. Int J Oncol.
39:935–940. 2011.PubMed/NCBI
|
|
15
|
Kim HS, Kim T, Ko H, Lee J, Kim YS and Suh
YG: Identification of galiellalactone-based novel STAT3-selective
inhibitors with cytotoxic activities against triple-negative breast
cancer cell lines. Bioorg Med Chem. 25:5032–5040. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang C, Long J, Liu B, Xu M, Wang W, Xie
X, Wang X and Kuang M: miR-500a-3p promotes cancer stem cells
properties via STAT3 pathway in human hepatocellular carcinoma. J
Exp Clin Cancer Res. 36:992017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Niwa Y, Kanda H, Shikauchi Y, Saiura A,
Matsubara K, Kitagawa T, Yamamoto J, Kubo T and Yoshikawa H:
Methylation silencing of SOCS-3 promotes cell growth and migration
by enhancing JAK/STAT and FAK signalings in human hepatocellular
carcinoma. Oncogene. 24:6406–6417. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aggarwal BB, Kunnumakkara AB, Harikumar
KB, Gupta SR, Tharakan ST, Koca C, Dey S and Sung B: Signal
transducer and activator of transcription-3, inflammation, and
cancer: How intimate is the relationship? Ann N Y Acad Sci.
1171:59–76. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang SW and Sun YM: The IL-6/JAK/STAT3
pathway: Potential therapeutic strategies in treating colorectal
cancer (Review). Int J Oncol. 44:1032–1040. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang SW, Hu J, Guo QH, Zhao Y, Cheng JJ,
Zhang DS, Fei Q, Li J and Sun YM: AZD1480, a JAK inhibitor,
inhibits cell growth and survival of colorectal cancer via
modulating the JAK2/STAT3 signaling pathway. Oncol Rep.
32:1991–1998. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang P, Enomoto A, Jijiwa M, Kato T,
Hasegawa T, Ishida M, Sato T, Asai N, Murakumo Y and Takahashi M:
An actin-binding protein Girdin regulates the motility of breast
cancer cells. Cancer Res. 68:1310–1318. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gu F, Wang L, He J, Liu X, Zhang H, Li W,
Fu L and Ma Y: Girdin, an actin-binding protein, is critical for
migration, adhesion, and invasion of human glioblastoma cells. J
Neurochem. 131:457–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang H, Misaki T, Taupin V, Eguchi A,
Ghosh P and Farquhar MG: GIV/girdin links vascular endothelial
growth factor signaling to Akt survival signaling in podocytes
independent of nephrin. J Am Soc Nephrol. 26:314–327. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dunkel Y, Ong A, Notani D, Mittal Y, Lam
M, Mi X and Ghosh P: STAT3 protein up-regulates Gα-interacting
vesicle-associated protein (GIV)/Girdin expression, and GIV
enhances STAT3 activation in a positive feedback loop during wound
healing and tumor invasion/metastasis. J Biol Chem.
287:41667–41683. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jin F, Liu C, Guo Y, Chen H and Wu Y:
Clinical implications of Girdin and PI3K protein expression in
breast cancer. Oncol Lett. 5:1549–1553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao L, Ma S, Liu Q and Liang P: Clinical
implications of girdin protein expression in glioma.
ScientificWorldJournal. 2013:9860732013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Yuan L, Yang XM, Wei D, Wang B,
Sun XX, Feng F, Nan G, Wang Y, Chen ZN and Bian H: A chimeric
antibody targeting CD147 inhibits hepatocellular carcinoma cell
motility via FAK-PI3K-Akt-Girdin signaling pathway. Clin Exp
Metastasis. 32:39–53. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang C, Lin J, Li L and Wang Y: Expression
and clinical significance of girdin in gastric cancer. Mol Clin
Oncol. 2:425–428. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang YJ, Li AJ, Han Y, Yin L and Lin MB:
Inhibition of Girdin enhances chemosensitivity of colorectal cancer
cells to oxaliplatin. World J Gastroenterol. 20:8229–8236. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ni W, Fang Y, Tong L, Tong Z, Yi F, Qiu J,
Wang R and Tong X: Girdin regulates the migration and invasion of
glioma cells via the PI3K-Akt signaling pathway. Mol Med Rep.
12:5086–5092. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu L, Sun Y, Li J, Wang Y, Zhu Y, Shi Y,
Fan X, Zhou J, Bao Y, Xiao J, et al: Silencing the Girdin gene
enhances radio-sensitivity of hepatocellular carcinoma via
suppression of glycolytic metabolism. J Exp Clin Cancer Res.
36:1102017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schonberg DL, Lubelski D, Miller TE and
Rich JN: Brain tumor stem cells: Molecular characteristics and
their impact on therapy. Mol Aspects Med. 39:82–101. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang KC, Wu MH, Jones D, Chen FF and
Tseng YL: Activation of STAT3 in thymic epithelial tumours
correlates with tumour type and clinical behaviour. J Pathol.
210:224–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Murray PJ: The JAK-STAT signaling pathway:
Input and output integration. J Immunol. 178:2623–2629. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kowshik J, Baba AB, Giri H, Deepak Reddy
G, Dixit M and Nagini S: Astaxanthin inhibits JAK/STAT-3 signaling
to abrogate cell proliferation, invasion and angiogenesis in a
hamster model of oral cancer. PLoS One. 9:e1091142014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Peng HX, Wu WQ, Yang DM, Jing R, Li J,
Zhou FL, Jin YF, Wang SY and Chu YM: Role of B7-H4 siRNA in
Proliferation, Migration, and Invasion of LOVO colorectal carcinoma
cell line. Biomed Res Int. 2015:3269812015. View Article : Google Scholar : PubMed/NCBI
|
